VIVAN Life Sciences Blog
US pharma sector welcomes India’s intellectual property policy
The US pharma sector has welcomed India’s recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed by the country’s pharma sector to US companies.
Acknowledging the “measured and cautious approach” of India in responding to recent requests for compulsory licenses and the successes some companies in enforcing their patents in at the preliminary injunction stage, representative of Pharmaceutical R ..
